百科

(2E,6E)-methyl-8-acetoxy-6-methylocta-2,6-dienoate

(2E,6E)-methyl-8-acetoxy-6-methylocta-2,6-dienoate

CAS号：110965-84-9

英文名：(2E,6E)-methyl-8-acetoxy-6-methylocta-2,6-dienoate

分子式

C12H18O4

熔点

密度

分子量

226.269

沸点

溶解度

信号词

危险品标志

若想填写更详细的询价信息，请点击进入询价页面

点我

基本信息

中文名称

(2E,6E)-methyl-8-acetoxy-6-methylocta-2,6-dienoate

英文名称

(2E,6E)-methyl-8-acetoxy-6-methylocta-2,6-dienoate

中文别名

英文别名

CAS号

110965-84-9

分子式

C12H18O4

分子量

226.269

精确质量

226.121

PSA

52.6

LOGP

2.0052

下游产品

共找到19个下游商品 >

(E)-6-((2R,3R)-2-((E)-5-((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-4-methylhex-3-en-1-ol

(E)-6-((2R,3R)-2-((E)-5-((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-4-methylhex-3-en-1-ol

(E)-methyl 8-((2R,3R)-2-((E)-5-((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-2-(dimethoxyphosphoryl)-6-methyloct-5-enoate

(E)-methyl 8-((2R,3R)-2-((E)-5-((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-2-(dimethoxyphosphoryl)-6-methyloct-5-enoate

anti-(1Z,5E)-1-(N,N-diisopropylcarbamoyloxy)-6-methyl-9-tert-butyldimethylsilyloxy-3-((E)-3-methyl-3,5-hexadienyl)-1,5-nonadien-4-ol

anti-(1Z,5E)-1-(N,N-diisopropylcarbamoyloxy)-6-methyl-9-tert-butyldimethylsilyloxy-3-((E)-3-methyl-3,5-hexadienyl)-1,5-nonadien-4-ol

methyl (E,E)-6-methyl-7-formyl-2,6-octadienoate

methyl (E,E)-6-methyl-7-formyl-2,6-octadienoate

rel-(ξ,4S,5S)-4-[(E)-3-methyl-6-iodo-3-hexenyl]-5-[(E)-2-methyl-5-tert-butyldimethylsilyloxy-1-pentenyl]-2-methoxy-1-oxacyclopentane

rel-(ξ,4S,5S)-4-[(E)-3-methyl-6-iodo-3-hexenyl]-5-[(E)-2-methyl-5-tert-butyldimethylsilyloxy-1-pentenyl]-2-methoxy-1-oxacyclopentane

(2E,6E)-methyl 8-hydroxy-6-methylocta-2,6-dienoate

(2E,6E)-methyl 8-hydroxy-6-methylocta-2,6-dienoate

下游产品

(E)-6-((2R,3R)-2-((E)-5-((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-4-methylhex-3-en-1-ol (E)-methyl 8-((2R,3R)-2-((E)-5-((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-2-(dimethoxyphosphoryl)-6-methyloct-5-enoate anti-(1Z,5E)-1-(N,N-diisopropylcarbamoyloxy)-6-methyl-9-tert-butyldimethylsilyloxy-3-((E)-3-methyl-3,5-hexadienyl)-1,5-nonadien-4-ol methyl (E,E)-6-methyl-7-formyl-2,6-octadienoate rel-(ξ,4S,5S)-4-[(E)-3-methyl-6-iodo-3-hexenyl]-5-[(E)-2-methyl-5-tert-butyldimethylsilyloxy-1-pentenyl]-2-methoxy-1-oxacyclopentane (2E,6E)-methyl 8-hydroxy-6-methylocta-2,6-dienoate rel-(2ξ,4S,5S)-4-[(E)-3-methyl-6-hydroxy-3-hexenyl]-5-[(E)-2-methyl-5-tert-butyldimethylsilyloxy-1-pentenyl]-2-methoxy-1-oxacyclopentane rel-(ξ,4S,5S)-4-[(E)-3-methyl-7-(dimethoxyphosphinyl)-7-carbomethoxy-3-octenyl]-5-[(E)-4-formyl-2-methyl-1-butenyl]-2-methoxy-1-oxacyclopentane (2E,6E)-6-methylnona-2,6,8-trien-1-ol rel-(2ξ,4R,5R)-4-[(E)-3-methyl-3,5-hexadienyl]-5-[(E)-2-methyl-5-tert-butyldimethylsilyloxy-1-pentenyl]-1-oxacyclopentan-2-ol (E)-methyl 2-(dimethoxyphosphoryl)-8-((2R,3R)-2-((E)-5-hydroxy-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-6-methyloct-5-enoate methyl (E,E)-6-methyl-2,6,8-nonatrienonate rel-(1R,14R)-(2E,6Z,10E)-3,11-dimethyl-7-carbomethoxy-17-oxa-16-oxabicyclo[12.3.0]hexadeca-2,6,10-triene methyl (E)-2-(bis(2,2,2-trifluoroethoxy)phosphoryl)-8-((2R,3R)-2-((E)-5-hydroxy-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-6-methyloct-5-enoate methyl (E)-2-(bis(2,2,2-trifluoroethoxy)phosphoryl)-8-((2R,3R)-2-((E)-5-((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-5-methoxytetrahydrofuran-3-yl)-6-methyloct-5-enoate N,N-diisopropyl (E,E)-6-methyl-2,6,8-nonatrienyl carbamate (3aR,6E,10Z,14E,15aR)-methyl 2-hydroxy-6,14-dimethyl-2,3,3a,4,5,8,9,12,13,15a-decahydrocyclotetradeca[b]furan-10-carboxylate (6E,10Z,14Z)-6,14-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,12,13,15a-octahydrocyclotetradeca[b]furan-10-carboxylic acid (3S,3aR,6E,10Z,14E,15aR)-methyl 3-(hydroxymethyl)-6,14-dimethyl-2-oxo-2,3,3a,4,5,8,9,12,13,15a-decahydrocyclotetradeca[b]furan-10-carboxylate